» Authors » Tomasz M Karpinski

Tomasz M Karpinski

Explore the profile of Tomasz M Karpinski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 80
Citations 1934
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Karpinski T, Korbecka-Paczkowska M, Stasiewicz M, Mrozikiewicz A, Wlodkowic D, Cielecka-Piontek J
Antibiotics (Basel) . 2025 Jan; 14(1). PMID: 39858316
Background/objectives: rapidly acquires antibiotic resistance and demonstrates increasing tolerance to antiseptics. This study evaluated the activity of eight antiseptics against , assessed its ability to develop adaptation to these antiseptics,...
2.
Sagan B, Czerny B, Stasilowicz-Krzemien A, Szulc P, Skomra U, Karpinski T, et al.
Foods . 2025 Jan; 13(24. PMID: 39767097
Hops ( L.) are widely recognized for their use in brewing, but they also possess significant pharmacological properties due to their rich bioactive compounds, with many varieties exhibiting diverse characteristics....
3.
Gosciniak A, Kocaj F, Stasilowicz-Krzemien A, Szymanski M, Karpinski T, Cielecka-Piontek J
Gels . 2024 Dec; 10(12). PMID: 39727528
The therapeutic potential of L. extract has gained significant attention due to its diverse medical applications. Sublingual administration remains a common delivery method of cannabinoids; however, challenges often arise due...
4.
Goderska K, Juzwa W, Karpinski T
Molecules . 2024 Nov; 29(22). PMID: 39598789
The aim of this study was to quantitatively analyse lactobionic acid obtained from bioreactor cultures using whey as a liquid medium with bacteria of the species. The most important culture...
5.
Karpinski T, Korbecka-Paczkowska M, Ozarowski M, Wlodkowic D, Wyganowska M, Seremak-Mrozikiewicz A, et al.
Pharmaceuticals (Basel) . 2024 Nov; 17(11). PMID: 39598453
Adaptation can reduce or completely eliminate the effectiveness of antibiotics and antiseptics at clinical concentrations. To our knowledge, no studies have examined fungal adaptation to antiseptics. This study aimed to...
6.
Paczkowska-Walendowska M, Karpinski T, Garbiec E, Walendowski M, Cielecka-Piontek J
Materials (Basel) . 2024 Nov; 17(21). PMID: 39517510
This study explores for the first time the impact of chitosan (CS) with varying molecular weights (MW), orange peel extract concentration, and hydroxypropyl methylcellulose (HPMC) content on the formulation of...
7.
Kiganda I, Wieske L, Nchiozem-Ngnitedem V, Chalo D, Umereweneza D, Ndakala A, et al.
J Nat Prod . 2024 Sep; 87(9):2263-2271. PMID: 39255387
Three new dihydroflavonols, gloverinols A-C (-), a new flavon-3-ol, gloverinol D (), two new isoflavans, gloveriflavan A () and B (), and seven known compounds were isolated from the root...
8.
Camilleri E, Blundell R, Baral B, Karpinski T, Aruci E, Atrooz O
Heliyon . 2024 Aug; 10(15):e35638. PMID: 39170453
This literature review offers an extensive exploration of Chaga mushrooms (), focusing on their phytochemical composition, health-promoting attributes, and mechanisms of action. The aim was to provide an up-to-date overview...
9.
Hassan S, Samanta S, Dash R, Karpinski T, Habibi E, Sadiq A, et al.
Front Pharmacol . 2024 Jun; 15:1431842. PMID: 38933671
[This corrects the article DOI: 10.3389/fphar.2022.1015835.].
10.
Paczkowska-Walendowska M, Ignacyk M, Miklaszewski A, Plech T, Karpinski T, Kwiatek J, et al.
Materials (Basel) . 2024 Jun; 17(11). PMID: 38893822
Pomegranate peel extract is known for its potent antibacterial, antiviral, antioxidant, anti-inflammatory, wound healing, and probiotic properties, leading to its use in treating oral infections. In the first stage of...